NEW YORK (GenomeWeb News) — Sequenom today said third-quarter revenues increased 43 percent as R&D spending rose 16 percent and losses decreased by 16 percent.
 
Total receipts for the three months ended Sept. 30 increased to $6.5 million from $4.6 million year over year.
 
R&D spending increased to $3 million from $2.6 million year over year.
 
The company said losses declined to $5.3 million from $6.3 million in the year-ago period.
 

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have an account?
Login Now.

The New York Times and ProPublica look into the close relationship between a startup and Memorial Sloan Kettering Cancer Center.

Yahoo News reports millions of dollars are being transferred from NIH, CDC, and other programs to pay for the housing of detained undocumented immigrant children.

In Science this week: in vitro generation of human reproductive cells, and more.

Researchers gave a handful of octopuses MDMA to find that they too act more social on the drug, Gizmodo reports.